Medspira

Executive Summary

Medspira is a privately held medical device company based in Minneapolis, MN, focused on advancing anorectal diagnostics and therapy. Founded in 2008, the company's flagship product, mcompass®, is a portable, easy-to-use system that enables anorectal manometry and pelvic floor biofeedback therapy in office settings. By making sophisticated diagnostic and therapeutic tools accessible to a broader range of healthcare professionals, Medspira aims to improve outcomes for patients with pelvic floor disorders, a common but often underdiagnosed condition. The company operates in the gastroenterology and medical device sectors, targeting a growing market driven by aging populations and increased awareness of pelvic health. Medspira's competitive advantage lies in its portable, user-friendly design that facilitates point-of-care testing and therapy, reducing the need for specialized referral centers. The company has potential for growth through expanded indications, new product iterations, and broader market penetration in the U.S. and internationally. While no specific financial data or recent funding rounds are public, the company's niche focus and established product suggest a steady trajectory. Key upcoming catalysts include potential FDA clearances for upgraded versions, strategic partnerships with large gastroenterology networks, and positive clinical data that could drive adoption and reimbursement.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for next-generation mcompass system with enhanced features70% success
• Q3 2026Partnership with a major gastroenterology practice network for nationwide rollout50% success
• Q2 2026Publication of pivotal clinical study demonstrating improved patient outcomes60% success